Cardinal Health stock: First-quarter results are set for November 5, 2026

Published on 10/23/2026 at 15:52 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Cardinal Health will report first-quarter results on November 5, 2026. Cardinal Health stock stood at EUR 227.30 on October 23, 2026.

Reporting date and trading level

Cardinal Health will report first-quarter fiscal 2027 results on November 5, 2026.
Adjusted earnings per share reached USD 2.91 in the quarter reported on August 11, 2026, versus USD 2.42 expected.
Cardinal Health stock stood at EUR 227.30 at Lang & Schwarz on October 23, 2026 at 3:38 p.m. CEST.

Geometrisches Bauhaus-Poster mit Text PHARMA DISTRIBUTION in Rot und Schwarz — Bauhaus-Poster für Cardinal Health Inc. zeigt geometrische Pharma-Distribution-Grafik – NYSE ISIN US14149Y1082, Illustration mit AI erstellt.

Cardinal Health (ISIN US14149Y1082) will report first-quarter fiscal 2027 results on November 5, 2026, before trading begins in New York, according to Cardinal Health. The stock stood at EUR 227.30 at Lang & Schwarz on October 23, 2026 at 3:38 p.m. CEST.

Quarterly earnings set the benchmark

The latest reported quarter delivered adjusted earnings per share of USD 2.91, compared with a consensus estimate of USD 2.42. Revenue reached USD 63.67 billion and increased 5.80 percent year over year in the quarter reported on August 11, 2026, according to MarketBeat. The earnings comparison gives investors a clear baseline for the November release.

Stock remains near its yearly high

Cardinal Health last traded at USD 254.09 on the NYSE on October 23, 2026 at 9:52 a.m. EDT. Its 52-week range was USD 158.70 to USD 259.21, placing the quote USD 5.12 below the high. The market capitalization was USD 58.8 billion, while trading volume stood at 67,836 shares at that time.

Valuation meets a firm date

The primary listing is on the NYSE under ticker CAH, and the company belongs to the S&P 500. The next earnings date matters because management is expected to provide the first fresh fiscal 2027 operating update since the current annual outlook was issued. Cardinal Health operates pharmaceutical distribution and medical-product businesses serving pharmacies, hospitals and other healthcare providers.

What the November release must clarify

The central comparison will be between the USD 2.91 adjusted earnings per share reported in the latest quarter and the estimate available before the November 5 release. Revenue growth of 5.80 percent in the August 11 report also sets a measurable test for the new quarter.

Trading level and next date

Cardinal Health stock combines a current euro indication with a scheduled earnings date that is less than two weeks away. The November report should provide the next dated operating figures for investors assessing earnings growth and the company's valuation.

The further course of trading is shown by the continuously updated real-time quote of Cardinal Health stock.